Plan of the Day Radiotherapy
Not Applicable
Recruiting
- Conditions
- Cervix Cancer
- Interventions
- Radiation: Plan of the dayRadiation: Standard plan
- Registration Number
- NCT05634681
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
The study objectives are to improve the treatment of LACC patients and to increase knowledge of the potential benefit of the plan-of-the-day concept on side effects during and after radiotherapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 190
Inclusion Criteria
- Histologically confirmed cervical cancer eligible for definitve radiochemotherapy
- FIGO stage IB1-IVa
- Over 18 years
- Speaks and understands Norwegian or English.
- ECOG 0-2
- Histology: Squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma
- Ability to understand and fill in patient questionnaires, and willing to sign a written informed consent
- Large movers (LM), fundus movement ≥2,5 cm.
Exclusion Criteria
- Evidence of distant metastasis. Suspicious paraaortic lymphnodes below the renal vessels is allowed if they are covered by the radiation field
- Patients with previous surgery for their cervical cancer
- Uncontrolled intercurrent somatic illness.
- Psychiatric illness /social situations limiting study compliance
- Prior radiotherapy to the pelvis
- Patients who are pregnant or breastfeeding is excluded due to risk of teratogenic and abortifacient effects of radiotherapy and cisplatin, and the potential risk of adverse effect of nursing infants
- Patients under current treatment for other invasive s except non-melanoma skin cancers
- Nephrostomy
- Patients with inflammatory bowel disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention arm Plan of the day - Control arm Standard plan -
- Primary Outcome Measures
Name Time Method To investigate whether implementation of the plan of the day concept results in less gastro-intestinal toxicity. 5 weeks To compare the change in patient reported acute diarrhea from baseline to week 4 from start of the treatment and to the end of external radiotherapy.
Item 17 in EORTC QLQ-C30
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oslo University Hospital
🇳🇴Oslo, Norway